← Leaderboards
Ute M Moll
State University New York Stony Brook
$14,001,329
Attributed
$14,001,329
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $916.9K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$14,001,329 · 6
By mechanism
R01$13,991,329 · 5
R13$10,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoCellsGeneticTumor Suppressor ProteinsGenesMediatingProteinsAblationMutantMouse ModelTp53 GenePhenotypeTumorBaseMutationTissuesApoptosisComplexGenetic TranscriptionExhibitsProgramsMalignant NeoplasmsFamilyGrant
Grant awards (43)
A novel role for E2fs: E2f7 and E2f8 control motile ciliogenesis$562,781
R01 · FY2024 · HL · contact PI
A novel role for E2fs: E2f7 and E2f8 control motile ciliogenesis$586,786
R01 · FY2023 · HL · contact PI
A novel role for E2fs: E2f7 and E2f8 control motile ciliogenesis$577,202
R01 · FY2022 · HL · contact PI
Mutant p53 as actionable cancer-specific target$337,545
R01 · FY2022 · CA · contact PI
A novel role for E2fs: E2f7 and E2f8 control motile ciliogenesis$572,417
R01 · FY2021 · HL · contact PI
Mutant p53 as actionable cancer-specific target$344,434
R01 · FY2021 · CA · contact PI
Mutant p53 as actionable cancer-specific target$374,348
R01 · FY2020 · CA · contact PI
Mutant p53 as actionable cancer-specific target$384,974
R01 · FY2019 · CA · contact PI
HL-p73 is a novel master regulator of the airway epithelium$494,753
R01 · FY2018 · HL · contact PI
Mutant p53 as actionable cancer-specific target$382,587
R01 · FY2018 · CA · contact PI
HL-p73 is a novel master regulator of the airway epithelium$494,753
R01 · FY2017 · HL · contact PI
Targeting stabilized mutant p53 protein$356,514
R01 · FY2017 · CA · contact PI
HL-p73 is a novel master regulator of the airway epithelium$467,126
R01 · FY2016 · HL · contact PI
Targeting stabilized mutant p53 protein$356,514
R01 · FY2016 · CA · contact PI
HL-p73 is a novel master regulator of the airway epithelium$485,641
R01 · FY2015 · HL · contact PI
Targeting stabilized mutant p53 protein$356,514
R01 · FY2015 · CA · contact PI
Targeting stabilized mutant p53 protein$345,545
R01 · FY2014 · CA · contact PI
Targeting stabilized mutant p53 protein$332,817
R01 · FY2013 · CA · contact PI
The in vivo role of the mitochondrial p53 cell death program$250,252
R01 · FY2013 · CA · contact PI
The role of p63 and p73 in cancer$305,188
R01 · FY2012 · CA · contact PI
The in vivo role of the mitochondrial p53 cell death program$266,225
R01 · FY2012 · CA · contact PI
The role of p63 and p73 in cancer$305,188
R01 · FY2011 · CA · contact PI
The in vivo role of the mitochondrial p53 cell death program$266,225
R01 · FY2011 · CA · contact PI
The role of p63 and p73 in cancer$314,296
R01 · FY2010 · CA · contact PI
The in vivo role of the mitochondrial p53 cell death program$273,881
R01 · FY2010 · CA · contact PI
The role of p63 and p73 in cancer$312,641
R01 · FY2009 · CA · contact PI
The in vivo role of the mitochondrial p53 cell death program$272,728
R01 · FY2009 · CA · contact PI
The role of p63 and p73 in cancer$235,373
R01 · FY2008 · CA · contact PI
Role of the p53 homolog p73 in cancer$77,268
R01 · FY2008 · CA · contact PI
The Apoptogenic Role of p53 at the Mitochondria$264,543
R01 · FY2007 · CA · contact PI
Role of the p53 homolog p73 in cancer$77,500
R01 · FY2007 · CA · contact PI
Role of the p53 homolog p73 in cancer$294,294
R01 · FY2006 · CA · contact PI
The Apoptogenic Role of p53 at the Mitochondria$272,444
R01 · FY2006 · CA · contact PI
Role of the p53 homolog p73 in cancer$301,376
R01 · FY2005 · CA
The Apoptogenic Role of p53 at the Mitochondria$276,300
R01 · FY2005 · CA
Third International Mdm2 Workshop$10,000
R13 · FY2005 · CA
Role of the p53 homolog p73 in cancer$301,376
R01 · FY2004 · CA
Apoptogenic Role of p53 at the Mitochondria$273,600
R01 · FY2004 · CA
Role of the p53 homolog p73 in cancer$301,376
R01 · FY2003 · CA
Role of the p53 homolog p73 in cancer$301,376
R01 · FY2002 · CA
P53S DIRECT ROLE IN MITOCHONDRIAL CONTROL OF APOPTOSIS$217,827
R01 · FY2002 · CA
P53S DIRECT ROLE IN MITOCHONDRIAL CONTROL OF APOPTOSIS$211,480
R01 · FY2001 · CA
P53S DIRECT ROLE IN MITOCHONDRIAL CONTROL OF APOPTOSIS$205,321
R01 · FY2000 · CA